Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

BACKGROUND: High throughput molecular screening techniques allow the identification of multiple molecular alterations, some of which are actionable and can be targeted by molecularly targeted agents (MTA). We aimed at evaluating the relevance of using this approach in the frame of Institut Curie Mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Basse, Clémence, Morel, Claire, Alt, Marie, Sablin, Marie Paule, Franck, Coralie, Pierron, Gaëlle, Callens, Céline, Melaabi, Samia, Masliah-Planchon, Julien, Bataillon, Guillaume, Gardrat, Sophie, Lavigne, Marion, Bonsang, Benjamin, Vaflard, Pauline, Pons Tostivint, Elvire, Dubot, Coraline, Loirat, Delphine, Marous, Miguelle, Geiss, Romain, Clément, Nathalie, Schleiermacher, Gudrun, Kamoun, Choumouss, Girard, Elodie, Ardin, Maude, Benoist, Camille, Bernard, Virginie, Mariani, Odette, Rouzier, Roman, Tresca, Patricia, Servois, Vincent, Vincent-Salomon, Anne, Bieche, Ivan, Le Tourneau, Christophe, Kamal, Maud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890857/
https://www.ncbi.nlm.nih.gov/pubmed/29636991
http://dx.doi.org/10.1136/esmoopen-2018-000339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890857/
https://www.ncbi.nlm.nih.gov/pubmed/29636991
http://dx.doi.org/10.1136/esmoopen-2018-000339

Ejemplares similares